Area under curve of Ascending colon T1 measured on MRI , in milliseconds. Measurements at 0, 1, 2, 3, 4, 5, 6, 7, and 8 hours post-intervention
| Group | Value | 95% CI |
|---|---|---|
| Kiwifruit | 312 | ± 92 |
| Control | 256 | ± 97 |
Last reviewed · How we verify
Effect of Kiwifruit on Gastrointestinal Fluid Distribution and Transit in Healthy Volunteers
NA trial testing MRI Scan in Constipation in 16 participants. Completed in 1 June 2018.
| Lead sponsor | University of Nottingham |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 16 |
| Start date | 27 June 2017 |
| Primary completion | 1 November 2017 |
| Estimated completion | 1 June 2018 |
| Sites | 1 location across United Kingdom |
University of Nottingham
Adults 18 to 65, any sex, with Constipation or Diet Modification. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Area under curve of Ascending colon T1 measured on MRI , in milliseconds. Measurements at 0, 1, 2, 3, 4, 5, 6, 7, and 8 hours post-intervention
| Group | Value | 95% CI |
|---|---|---|
| Kiwifruit | 312 | ± 92 |
| Control | 256 | ± 97 |
Area under the curve of change of small bowel water, 0-8 hours, measured by MRI, in mL Measurements at 0, 1, 2, 3, 4, 5, 6, 7, and 8 hours post-intervention
| Group | Value | 95% CI |
|---|---|---|
| Kiwifruit | 85530 | ± 34923 |
| Control | 35023 | ± 15557 |
Ascending (AC), transverse (TC) and descending (DC) colonic volumes, measured by MRI, in mL Data given: AUC for total colon Measurements at 0, 1, 2, 3, 4, 5, 6, 7, and 8 hours post-intervention
| Group | Value | 95% CI |
|---|---|---|
| Kiwifruit | 283583 | ± 59402 |
| Control | 243182 | ± 46682 |
Transit of markers through gut as assessed by the weighted average position score (total score 0-7, calculated from a score of 0-7 of each of the 5 marker pills) at 24 h on MRI A lower score indicates faster transit.
| Group | Value | 95% CI |
|---|---|---|
| Kiwifruit | 0.8 | 0 – 1.4 |
| Control | 1.0 | 0.5 – 3.1 |
Assessment, via Diary, of bowel frequency Data given: stool frequency
| Group | Value | 95% CI |
|---|---|---|
| Kiwifruit | 1.46 | ± 0.66 |
| Control | 1.14 | ± 0.46 |
Constipation is a widespread and common problem in which a person finds it difficult and/or painful to open their bowels. The current treatment is the use of medications called laxatives. Kiwifruit is a widely available food that has been shown to possess some laxative properties. The cause of this is unknown. Non-invasive medical imaging techniques such as Magnetic Resonance Imaging now allow taking pictures of the gut and its contents. The Nottingham GI MRI research group specialises in these techniques and in this study use such images to assess the changes induced in the gut contents by kiwifruit to improve understanding of how it helps patients with constipation. The volunteers will be asked to undergo 2 studies in which they take either kiwifruit or placebo (sugary drink) two times a day for 2 days and then spend a study day where will they will be fed some more kiwifruit/placebo and some normal food and image their gut at intervals. Participants will be asked to complete a stool diary to determine if they experience a laxative effect.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Trials testing the same drug.
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03303417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing